Louisiana State Employees Retirement System Abb Vie Inc. Transaction History

Louisiana State Employees Retirement System

$5.11 Billion
Q2 2024

A detailed history of Louisiana State Employees Retirement System transactions in Abb Vie Inc. stock. As of the latest transaction made, Louisiana State Employees Retirement System holds 99,900 shares of ABBV stock, worth $19.5 Million. This represents 0.34% of its overall portfolio holdings.

Number of Shares

99,900

Previous 102,800 2.82%

Holding current value

$19.5 Million

Previous $18.7 Million 8.47%

% of portfolio

0.34%

Previous 0.37%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 24, 2024	SELL	$154.79 - $180.76 $448,891 - $524,204	-2,900 Reduced 2.82%	99,900 $17.1 Million
Q1 2024 Apr 23, 2024	SELL	$159.82 - $182.1 $639,280 - $728,400	-4,000 Reduced 3.75%	102,800 $18.7 Million
Q4 2023 Jan 29, 2024	SELL	$137.6 - $154.97 $357,760 - $402,922	-2,600 Reduced 2.38%	106,800 $16.6 Million
Q3 2023 Oct 17, 2023	BUY	$133.59 - $154.65 $40,077 - $46,395	300 Added 0.27%	109,400 $16.3 Million
Q2 2023 Jul 18, 2023	SELL	$132.51 - $164.9 $781,809 - $972,910	-5,900 Reduced 5.13%	109,100 $14.7 Million
Q1 2023 Apr 19, 2023	BUY	$144.61 - $166.54 $101,227 - $116,578	700 Added 0.61%	115,000 $18.3 Million
Q4 2022 Jan 24, 2023	BUY	$138.31 - $165.87 $165,972 - $199,044	1,200 Added 1.06%	114,300 $18.5 Million
Q3 2022 Oct 19, 2022	BUY	$134.21 - $153.93 $161,052 - $184,716	1,200 Added 1.07%	113,100 $15.2 Million
Q2 2022 Jul 20, 2022	BUY	$137.62 - $174.96 $41,286 - $52,488	300 Added 0.27%	111,900 $16.8 Million
Q1 2022 Apr 22, 2022	BUY	$131.98 - $163.75 $105,583 - $131,000	800 Added 0.72%	111,600 $17.5 Million
Q4 2021 Jan 14, 2022	BUY	$107.43 - $135.93 $85,944 - $108,744	800 Added 0.73%	110,800 $15 Million
Q3 2021 Oct 12, 2021	SELL	$106.4 - $120.78 $10,640 - $12,078	-100 Reduced 0.09%	110,000 $11.9 Million
Q2 2021 Jul 16, 2021	BUY	$105.21 - $117.21 $73,647 - $82,047	700 Added 0.64%	110,100 $12.4 Million
Q1 2021 Apr 14, 2021	SELL	$102.3 - $112.62 $20,460 - $22,524	-200 Reduced 0.18%	109,400 $11.8 Million
Q4 2020 Jan 11, 2021	BUY	$80.49 - $108.67 $1.61 Million - $2.17 Million	20,000 Added 22.32%	109,600 $11.7 Million
Q3 2020 Oct 19, 2020	BUY	$85.91 - $100.83 $1.19 Million - $1.39 Million	13,800 Added 18.21%	89,600 $7.85 Million
Q2 2020 Jul 13, 2020	BUY	$73.37 - $98.18 $946,473 - $1.27 Million	12,900 Added 20.51%	75,800 $7.44 Million
Q1 2020 Apr 13, 2020	SELL	$64.5 - $97.79 $470,850 - $713,867	-7,300 Reduced 10.4%	62,900 $4.79 Million
Q4 2019 Jan 17, 2020	SELL	$72.13 - $90.25 $64,916 - $81,225	-900 Reduced 1.27%	70,200 $6.22 Million
Q3 2019 Oct 24, 2019	SELL	$62.98 - $75.72 $188,940 - $227,160	-3,000 Reduced 4.05%	71,100 $5.38 Million
Q2 2019 Jul 15, 2019	SELL	$65.7 - $83.98 $249,660 - $319,124	-3,800 Reduced 4.88%	74,100 $5.21 Million
Q1 2019 Apr 15, 2019	SELL	$77.14 - $90.79 $77,140 - $90,790	-1,000 Reduced 1.27%	77,900 $6.28 Million
Q4 2018 Jan 14, 2019	SELL	$77.85 - $96.01 $755,145 - $931,297	-9,700 Reduced 10.95%	78,900 $7.27 Million
Q3 2018 Oct 16, 2018	SELL	$88.91 - $98.84 $53,346 - $59,304	-600 Reduced 0.67%	88,600 $8.38 Million
Q2 2018 Jul 18, 2018	SELL	$89.78 - $106.23 $727,218 - $860,463	-8,100 Reduced 8.32%	89,200 $8.26 Million
Q1 2018 Apr 18, 2018	BUY	$92.01 - $123.21 $73,608 - $98,568	800 Added 0.83%	97,300 $9.21 Million
Q4 2017 Jan 16, 2018	SELL	$89.56 - $98.21 $268,680 - $294,630	-3,000 Reduced 3.02%	96,500 $9.33 Million
Q3 2017 Oct 16, 2017	BUY	$69.85 - $89.22 $6.95 Million - $8.88 Million	99,500	99,500 $8.84 Million

Others Institutions Holding ABBV

# of Institutions

3,694

Shares Held

1.27B

Call Options Held

13M

Put Options Held

9.79M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $344B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Louisiana State Employees Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on Louisiana State Employees Retirement System with notifications on news.

Account

Louisiana State Employees Retirement System Abb Vie Inc. Transaction History